Noteworthy impacts of COVID-19 pandemic on cancer screening:A systematic review

作     者：Huilin Wang Min Yang Wei Xiong Quan Wang Bobo Zheng Yang Bai Kaiyong Zou Jibin Li Jiansong Ren Wanqing Chen Jingbo Zhai Jiang Li 

作者机构：Office for Cancer ScreeningNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Comprehensive InterventionNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Gynecology Endocrine&Reproductive CenterNational Clinical Research Center for Obstetric&Gynecologic Diseases Department of Obstetrics and GynecologyPeking Union Medical College HospitalPeking Union Medical College/Chinese Academy of Medical SciencesBeijing 100005China Ambulatory Surgery Center of Xijing HospitalFourth Military Medical UniversityXi'an 710068China Department of General SurgeryShaanxi Provincial People’s HospitalXi'an 710068China College of Clinical MedicineCapital Medical UniversityBeijing 100069China School of Public HealthTianjin University of Traditional Chinese MedicineTianjin 301617China 

出 版 物：《Fundamental Research》 (自然科学基础研究（英文版）)

年 卷 期：2024年第4卷第3期

页      面：484-494页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：supported by Beijing Nova Program(z201100006820070) Hope Star Program by National Cancer Cente Peking Union Medical College Education Foundation and National High Level Hospital Clinical Research Funding(2022-PUMCH-A-235) 

主　　题：Cancer screening COVID-19 pandemic Cohort study Incidence rate ratio Meta-analysis 

摘      要：The sudden onset of the coronavirus disease 2019(COVID-19)in January 2020 has affected essential global health ***-screening services that can reduce cancer mortality are strongly ***,the specific role of COVID-19 in cancer screening is not fully *** study aimed to assess the efficiency of global cancer screening programs before and during the COVID-19 pandemic and to promote potential cancer-screening strategies for the next *** searches in PubMed,Embase,and Web of Science,and manual searches were performed between January 1,2020 and March 1,*** studies that reported the number of participants who underwent cancer screening before and during the COVID-19 pandemic were *** methodological quality of the included studies was assessed using the Newcastle-Ottawa *** in cancer-screening rates were estimated using the incidence rate ratio(IRR).Fifty-five cohort studies were included in this *** screening rates of colorectal cancer using invasive screening methods(Pooled IRR=0.52,95%CI:0.42 to 0.65,p0.01),cervical cancer(Pooled IRR=0.56,95%CI:0.47 to 0.67,p0.01),breast cancer(Pooled IRR=0.57,95%CI:0.49 to 0.66,p0.01)and prostate cancer(Pooled IRR=0.71,95%CI:0.56 to 0.90,p0.01)during the COVID-19 pandemic were significantly lower than those before the COVID-19 *** screening rates of lung cancer(Pooled IRR=0.77,95%CI:0.58 to 1.03,p=0.08)and colorectal cancer using noninvasive screening methods(Pooled IRR=0.74,95%CI:0.50 to 1.09,p=0.13)were reduced with no statistical *** subgroup analyses revealed that the reduction in cancer-screening rates varied across *** results suggest that the COVID-19 pandemic has had a noteworthy impact on colorectal,cervical,breast,and prostate cancer *** innovative cancer-screening technologies is important to promote the efficiency of cancer-screening services in the post-COVID-19 era and prepare fo